Skip to main content
. 2017 May 23;8(38):62998–63013. doi: 10.18632/oncotarget.18071

Table 2. Pattern of failure and the first failure.

Parameters N (%) χ2 values p values
All (N = 112) Early PORT (N = 41) Late PORT (N = 71)
LR as first site of failure
 Yes 21 (18.8) 6 (14.6) 15 (21.1) 0.72 0.40
 No 91 (81.2) 35 (85.4) 56 (78.9)
All LR failure
 Yes 24 (21.4) 8 (39.0) 16 (22.5) 0.14 0.71
 No 88 (78.6) 33 (61.0) 55 (77.5)
DM as first site of failure
 Yes 39 (34.8) 13 (31.7) 26 (36.6) 1.56 0.21
 No 73 (65.2) 28 (68.3) 45 (63.4)
All DM failure
 Yes 44 (39.3) 13 (31.7) 31 (43.7) 1.56 0.21
 No 68 (60.7) 28 (68.3) 40 (56.3)
Both LR and DM as first site of failure
 Yes 10 (8.9) 3 (7.3) 7 (9.9) 0.21 0.65
 No 102 (91.1) 38 (92.7) 64 (90.1)
Both LR and DM failure
 Yes 18 (16.1) 5 (12.2) 13 (18.3) 0.72 0.39
 No 94 (83.9) 36 (87.8) 58 (81.7)
Site of DM
 Lung 20 (17.9) 7 (17.1) 13 (18.3) - -
 Bone 14 (12.5) 3 (7.3) 11 (15.5)
 Lung pleura 7 (6.3) 3 (7.3) 4 (5.6)
 Central nervous system 6 (5.4) 2 (4.9) 4 (5.6)
 Adrenal gland 4 (3.5) 1 (2.4) 3 (4.2)
 Liver 4 (3.5) 2 (4.9) 2 (2.8)
 Others 6 (5.4) 1 (2.4) 5 (7.0)

Note: some patients had more than one site of LR or/and DM failure at the same time.

PORT: postoperative radiotherapy; LR: locoregional recurrence; DM: distant metastasis.

Fifteen patients concurrent with multiple metastases including lung, bone, lung pleura, central nervous system, adrenal gland, liver, or others.